Skip to main content
Top
Published in: European Archives of Psychiatry and Clinical Neuroscience 6/2018

01-09-2018 | Original Paper

Correspondence between negative symptoms and potential sources of secondary negative symptoms over time

Authors: Aida Farreny, Mark Savill, Stefan Priebe

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 6/2018

Login to get access

Abstract

There has been a debate in the literature about the distinction between primary and secondary negative symptoms of schizophrenia. Our aim was to study the associations between negative symptoms and potential sources of secondary negative symptoms over time. A sample of 275 participants with at least mid-moderate negative symptoms was randomized into body psychotherapy or Pilates class in a previous study. No significant differences were found between groups over time and changes in the symptom domains were modest. The present investigation considers the longitudinal correlation between variables of interest at baseline, 3 and 9 months follow-up. Measures were the Clinical Assessment Interview for Negative Symptoms (CAINS), the Positive and Negative Symptom Scale (PANSS), the Calgary Depression Scale (CDSS) and the Simpson–Angus Extrapyramidal side-effects Scale (SAS). Mixed models were computed to test the longitudinal association between these variables. In a sensitivity analysis, the dosages of antipsychotic, illness duration and allocated intervention were taken into account. Overall, the course of extrapyramidal side-effects, depressive and positive symptoms was significantly related to the course of negative symptoms. Only extrapyramidal effects were longitudinally correlated to expressive negative symptoms. The sensitivity analyses showed unaltered results for positive symptoms and depression but a lack of association between extrapyramidal effects and the CAINS outcomes. In conclusion, the unambiguous interpretation between primary and secondary negative symptoms may lead to refined treatment approaches for schizophrenia and to increased effects of the interventions.
Literature
2.
go back to reference Carpenter WT, Heinrichs DW, Alphs L (1985) Treatment of negative symptoms. Schizophr Bull 11:440–452CrossRefPubMed Carpenter WT, Heinrichs DW, Alphs L (1985) Treatment of negative symptoms. Schizophr Bull 11:440–452CrossRefPubMed
4.
go back to reference Carpenter WT Jr, Heinrichs WT, Wagman A (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145:578–583CrossRefPubMed Carpenter WT Jr, Heinrichs WT, Wagman A (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145:578–583CrossRefPubMed
8.
go back to reference Carpenter WT, Kirkpatrick B (2015) Correspondence: concepts and methods when considering negative symptom course. Psychol Med 45:2135–2136CrossRefPubMed Carpenter WT, Kirkpatrick B (2015) Correspondence: concepts and methods when considering negative symptom course. Psychol Med 45:2135–2136CrossRefPubMed
9.
go back to reference Czobor P, Volavka J (1996) Positive and negative symptoms: is their change related? Schizophr Bull 22:577–590CrossRefPubMed Czobor P, Volavka J (1996) Positive and negative symptoms: is their change related? Schizophr Bull 22:577–590CrossRefPubMed
10.
go back to reference Chen L, Johnston JA, Kinon BJ et al (2013) The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial. BMC Psychiatry 13:320. doi:10.1186/1471-244X-13-320 CrossRefPubMedPubMedCentral Chen L, Johnston JA, Kinon BJ et al (2013) The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial. BMC Psychiatry 13:320. doi:10.​1186/​1471-244X-13-320 CrossRefPubMedPubMedCentral
11.
20.
go back to reference World Health Organization (WHO) (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva World Health Organization (WHO) (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva
22.
go back to reference Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276CrossRefPubMed Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276CrossRefPubMed
23.
go back to reference Marder SR, Davis JM, Chouinard G (1997) The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry 58:538–546CrossRefPubMed Marder SR, Davis JM, Chouinard G (1997) The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry 58:538–546CrossRefPubMed
24.
go back to reference Addington D, Addington J, Maticka-Tyndale E (1993) Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl 22:39–44CrossRef Addington D, Addington J, Maticka-Tyndale E (1993) Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl 22:39–44CrossRef
26.
go back to reference Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11–19CrossRefPubMed Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11–19CrossRefPubMed
27.
go back to reference WHO Collaborating Centre for Drug Statistics Methodology (2013) Guidelines for ATC classification and DDD assignment. Norwegian Institute of Public Health, Oslo. doi:10.1021/la902623c CrossRef WHO Collaborating Centre for Drug Statistics Methodology (2013) Guidelines for ATC classification and DDD assignment. Norwegian Institute of Public Health, Oslo. doi:10.​1021/​la902623c CrossRef
30.
go back to reference IBM SPSS statistics for windows 22.0 (2013) IBM Corp, Armonk, New York IBM SPSS statistics for windows 22.0 (2013) IBM Corp, Armonk, New York
32.
go back to reference Klaassen RMC, Heins M, Luteijn LB et al (2013) Depressive symptoms are associated with (sub)clinical psychotic symptoms in patients with non-affective psychotic disorder, siblings and healthy controls. Psychol Med 43:747–756. doi:10.1017/S0033291712001572 CrossRefPubMed Klaassen RMC, Heins M, Luteijn LB et al (2013) Depressive symptoms are associated with (sub)clinical psychotic symptoms in patients with non-affective psychotic disorder, siblings and healthy controls. Psychol Med 43:747–756. doi:10.​1017/​S003329171200157​2 CrossRefPubMed
34.
35.
go back to reference Tandon R, DeQuardo JR, Taylor SF et al (2000) Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome. Schizophr Res 45:191–201CrossRefPubMed Tandon R, DeQuardo JR, Taylor SF et al (2000) Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome. Schizophr Res 45:191–201CrossRefPubMed
36.
go back to reference Artaloytia JF, Arango C, Lahti A et al (2006) Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. Am J Psychiatry 163:488–493. doi:10.1176/appi.ajp.163.3.488 CrossRefPubMed Artaloytia JF, Arango C, Lahti A et al (2006) Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. Am J Psychiatry 163:488–493. doi:10.​1176/​appi.​ajp.​163.​3.​488 CrossRefPubMed
37.
go back to reference Strauss JS, Carpenter WT, Bartko JJ (1974) The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 11:61–69CrossRef Strauss JS, Carpenter WT, Bartko JJ (1974) The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 11:61–69CrossRef
40.
Metadata
Title
Correspondence between negative symptoms and potential sources of secondary negative symptoms over time
Authors
Aida Farreny
Mark Savill
Stefan Priebe
Publication date
01-09-2018
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 6/2018
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-017-0813-y

Other articles of this Issue 6/2018

European Archives of Psychiatry and Clinical Neuroscience 6/2018 Go to the issue